BMC Medicine (Jan 2020)
Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study
- Heinz Freisling,
- Vivian Viallon,
- Hannah Lennon,
- Vincenzo Bagnardi,
- Cristian Ricci,
- Adam S. Butterworth,
- Michael Sweeting,
- David Muller,
- Isabelle Romieu,
- Pauline Bazelle,
- Marina Kvaskoff,
- Patrick Arveux,
- Gianluca Severi,
- Christina Bamia,
- Tilman Kühn,
- Rudolf Kaaks,
- Manuela Bergmann,
- Heiner Boeing,
- Anne Tjønneland,
- Anja Olsen,
- Kim Overvad,
- Christina C. Dahm,
- Virginia Menéndez,
- Antonio Agudo,
- Maria-Jose Sánchez,
- Pilar Amiano,
- Carmen Santiuste,
- Aurelio Barricarte Gurrea,
- Tammy Y. N. Tong,
- Julie A. Schmidt,
- Ioanna Tzoulaki,
- Konstantinos K. Tsilidis,
- Heather Ward,
- Domenico Palli,
- Claudia Agnoli,
- Rosario Tumino,
- Fulvio Ricceri,
- Salvatore Panico,
- H. Susan J. Picavet,
- Marije Bakker,
- Evelyn Monninkhof,
- Peter Nilsson,
- Jonas Manjer,
- Olov Rolandsson,
- Elin Thysell,
- Elisabete Weiderpass,
- Mazda Jenab,
- Elio Riboli,
- Paolo Vineis,
- John Danesh,
- Nick J. Wareham,
- Marc J. Gunter,
- Pietro Ferrari
Affiliations
- Heinz Freisling
- Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer
- Vivian Viallon
- Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer
- Hannah Lennon
- Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer
- Vincenzo Bagnardi
- Department of Statistics and Quantitative Methods, University of Milan Bicocca
- Cristian Ricci
- Centre of Excellence for Nutrition (CEN), North-West University
- Adam S. Butterworth
- Medical Research Council, British Heart Foundation, Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge
- Michael Sweeting
- Department of Public Health and Primary Care, University of Cambridge
- David Muller
- Department Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Isabelle Romieu
- Nutritional Epidemiology Group, International Agency for Research on Cancer
- Pauline Bazelle
- Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer
- Marina Kvaskoff
- Centre for Research in Epidemiology and Population Health (CESP), Inserm, Facultés de Médecine Universités Paris Sud, UVSQ, Université Paris Saclay, Gustave Roussy
- Patrick Arveux
- Centre for Research in Epidemiology and Population Health (CESP), Inserm, Facultés de Médecine Universités Paris Sud, UVSQ, Université Paris Saclay, Gustave Roussy
- Gianluca Severi
- Centre for Research in Epidemiology and Population Health (CESP), Inserm, Facultés de Médecine Universités Paris Sud, UVSQ, Université Paris Saclay, Gustave Roussy
- Christina Bamia
- WHO Collaborating Center for Nutrition and Health, Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens
- Tilman Kühn
- German Cancer Research Center (DKFZ)
- Rudolf Kaaks
- German Cancer Research Center (DKFZ)
- Manuela Bergmann
- Department of Epidemiology, German Institute of Human Nutrition Potsdam Rehbrücke
- Heiner Boeing
- Department of Epidemiology, German Institute of Human Nutrition Potsdam Rehbrücke
- Anne Tjønneland
- Danish Cancer Society Research Center
- Anja Olsen
- Danish Cancer Society Research Center
- Kim Overvad
- Department of Public Health, Aarhus University
- Christina C. Dahm
- Department of Public Health, Aarhus University
- Virginia Menéndez
- Public Health Directorate
- Antonio Agudo
- Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Institute for Biomedical Research (IDIBELL), L’Hospitalet de Llobregat
- Maria-Jose Sánchez
- CIBER Epidemiología y Salud Pública (CIBERESP)
- Pilar Amiano
- CIBER Epidemiología y Salud Pública (CIBERESP)
- Carmen Santiuste
- Department of Epidemiology, Murcia Regional Health Council, IMIB Arrixaca
- Aurelio Barricarte Gurrea
- CIBER Epidemiología y Salud Pública (CIBERESP)
- Tammy Y. N. Tong
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford
- Julie A. Schmidt
- Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford
- Ioanna Tzoulaki
- Department Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Konstantinos K. Tsilidis
- Department Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Heather Ward
- Department Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Domenico Palli
- Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network – ISPRO
- Claudia Agnoli
- Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori
- Rosario Tumino
- Civi M. Arezzo Hospital
- Fulvio Ricceri
- Città della Salute e della Scienza di Torino Hospital
- Salvatore Panico
- Department of Clinical and Experimental Medicine, Federico II University
- H. Susan J. Picavet
- Centre for Nutrition, Prevention and Health Services, National Institute for Public Health and the Environment
- Marije Bakker
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University
- Evelyn Monninkhof
- Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University
- Peter Nilsson
- Public Health and Clinical Medicine, Nutritional Research, Umeå University, and Arctic Research Centre at Umeå University
- Jonas Manjer
- Department of Surgery, Skåne University Hospital Malmö, Lund University
- Olov Rolandsson
- Department of Public Health and Clinical Medicine, Section of Family Medicine, Umeå University
- Elin Thysell
- Department of Medical Biosciences, Pathology, Umeå University
- Elisabete Weiderpass
- Director’s Office, International Agency for Research on Cancer
- Mazda Jenab
- Nutritional Epidemiology Group, International Agency for Research on Cancer
- Elio Riboli
- Department Epidemiology and Biostatistics, School of Public Health, Imperial College London
- Paolo Vineis
- Department Epidemiology and Biostatistics, School of Public Health, Imperial College London
- John Danesh
- Medical Research Council, British Heart Foundation, Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge
- Nick J. Wareham
- MRC Epidemiology Unit, School of Clinical Medicine, Institute of Metabolic Science, University of Cambridge
- Marc J. Gunter
- Nutritional Epidemiology Group, International Agency for Research on Cancer
- Pietro Ferrari
- Nutritional Methodology and Biostatistics Group, International Agency for Research on Cancer
- DOI
- https://doi.org/10.1186/s12916-019-1474-7
- Journal volume & issue
-
Vol. 18,
no. 1
pp. 1 – 11
Abstract
Abstract Background Although lifestyle factors have been studied in relation to individual non-communicable diseases (NCDs), their association with development of a subsequent NCD, defined as multimorbidity, has been scarcely investigated. The aim of this study was to investigate associations between five lifestyle factors and incident multimorbidity of cancer and cardiometabolic diseases. Methods In this prospective cohort study, 291,778 participants (64% women) from seven European countries, mostly aged 43 to 58 years and free of cancer, cardiovascular disease (CVD), and type 2 diabetes (T2D) at recruitment, were included. Incident multimorbidity of cancer and cardiometabolic diseases was defined as developing subsequently two diseases including first cancer at any site, CVD, and T2D in an individual. Multi-state modelling based on Cox regression was used to compute hazard ratios (HR) and 95% confidence intervals (95% CI) of developing cancer, CVD, or T2D, and subsequent transitions to multimorbidity, in relation to body mass index (BMI), smoking status, alcohol intake, physical activity, adherence to the Mediterranean diet, and their combination as a healthy lifestyle index (HLI) score. Cumulative incidence functions (CIFs) were estimated to compute 10-year absolute risks for transitions from healthy to cancer at any site, CVD (both fatal and non-fatal), or T2D, and to subsequent multimorbidity after each of the three NCDs. Results During a median follow-up of 11 years, 1910 men and 1334 women developed multimorbidity of cancer and cardiometabolic diseases. A higher HLI, reflecting healthy lifestyles, was strongly inversely associated with multimorbidity, with hazard ratios per 3-unit increment of 0.75 (95% CI, 0.71 to 0.81), 0.84 (0.79 to 0.90), and 0.82 (0.77 to 0.88) after cancer, CVD, and T2D, respectively. After T2D, the 10-year absolute risks of multimorbidity were 40% and 25% for men and women, respectively, with unhealthy lifestyle, and 30% and 18% for men and women with healthy lifestyles. Conclusion Pre-diagnostic healthy lifestyle behaviours were strongly inversely associated with the risk of cancer and cardiometabolic diseases, and with the prognosis of these diseases by reducing risk of multimorbidity.
Keywords
- Healthy lifestyle
- Obesity
- Cancer and cardiometabolic multimorbidity
- Cancer
- Cardiovascular disease
- Diabetes